While controversy swirls around the abortion inducing drug mifepristone, the Food and Drug Administration pulled a different pregnancy-related medication off the market.
A male pro powerlifter took advantage of lax “inclusive” gender identification policies to enter the Heroes Classic tournament in Alberta, Canada after